Post-authorization surveillance study comparing the efficacy and safety of Medabon (mifepristone/misoprostol) to historical data for early pregnancy termination (Medabon PASS)

18/02/2014
02/07/2024
EU PAS number:
EUPAS5783
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.74 MB - PDF) View document
Updated protocol
English (283.23 KB - PDF) View document
Study results
Study results
English (102.69 KB - PDF) View document
Study report
Other information